Locate Bio, who are developing new treatments for patients with serious spinal conditions, has completed a £2.25m funding round led by Mercia Asset Management to help to continue its ground-breaking research and bring its first products to market. Locate Bio has secured the investment from Mercia’s own balance sheet, its EIS...
PROTAC Assays – Successfully measuring Protein Degradation
PROTAC (PROteolysis TArgeting Chimera) is one of the hottest topics in drug discovery today as it is a highly promising new approach to targeted therapy. It offers several advantages over traditional occupancy-based drugs, with a potential to target the ‘undruggable’ proteome. Read Aurelia Bioscience's blog below to learn more about PROTAC...
A Practical Guide to Developing Software For Medical Devices
In eg Technology's final webinar of their Product Design and Development of Medical Device series, in association with SEHTA, eg technology Director, David Warwick, used his extensive knowledge and experience of computer systems engineering and medical device design to talk us through some practical advice on the development of software...
Bright Future for Life Sciences in the Midlands
The amalgamation of Medilink East and West Midlands has been given the seal of approval in a move which will serve the best interests of the life sciences sector in the Midlands. This unification, that sees Medilink East and West Midlands operate under a single group company, Medilink Midlands, was...
5 top tips for your first R&D Tax Credit Claim
There are many reasons why a company is yet to claim R&D Tax Relief. You might be a new business, a start-up or a university spin-out; you might have recently come across the scheme for the first time; you may have previously thought you were ineligible, or you may have...
UK-EU Trade Deal, What’s the State of Play?
A Business Leader’s View of the Negotiations Over the past few months, the UK’s focus has understandably been on managing the Coronavirus pandemic and subsequent lockdowns. But the question of Brexit has not gone away. Chief Executive of Morningside Pharmaceuticals, Dr Nik Kotecha OBE, gives his view on the negotiations. ...
Medilink East Midlands joins forces with Silverstone Technology Cluster
Medilink East Midlands has become the second significant industry sector body in as many months to announce a new data and technical-driven partnership with the Silverstone Technology Cluster (STC). Medilink EM is the East Midlands life science industry association whose aim is to help companies establish, develop and grow. It...
BHIB Executive Chairman Ashwin Mistry shortlisted for Director of the Year award
BHIB are proud to announce that their Executive Chairman, Ashwin Mistry, has been shortlisted for the Director of the Year award at this year’s Broker Innovation Awards. In association with Applied Systems – the world’s largest provider of cloud-based insurance software – the Broker Innovation Awards highlight and recognise the...
The benefits of R&D Tax Relief for Start-ups
During the first few years of a running a start-up business, claiming R&D Tax Relief may be far from the top of your priorities. However, making a claim could return a significant amount of much-needed cash to your business. Many technology-based start-up businesses are innovative by their very nature. They’re usually created...
Quotient Sciences Completes Million Dollar Pharmacy Expansion at Miami Clinic
Quotient Sciences, a global pharmaceutical development, clinical and commercial manufacturing organization, announced today the completion of a $1 million dollar pharmacy and laboratory expansion at their Miami, FL clinical pharmacology facility. The expanded pharmacy capabilities offer customers a quick and cost-effective way to start clinical testing, without the need for...
